C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2006
10/19/2006	US20060234219 Rapid and with high sensitivity; determining causative microorganisms of sepsis and those of bacteriemia
10/19/2006	US20060234218 P450 proteins
10/19/2006	US20060234217 Nucleic acid encodes a heat labile alkaline phosphatase, or the complementary sequence
10/19/2006	US20060234212 Hepatitis-B viral variants with reduced susceptibility to nucleoside analogs and uses thereof
10/19/2006	US20060233839 Novel compounds
10/19/2006	US20060233834 Production of poxviruses with adherent or non adherent avian cell lines
10/19/2006	US20060233832 Composition for the prophylaxis and treatment of HBV infections and HBV-mediated diseases
10/19/2006	US20060233829 Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
10/19/2006	US20060233827 85kDa neisserial antigen
10/19/2006	US20060233823 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/19/2006	US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
10/19/2006	US20060233821 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses
10/19/2006	US20060233820 Inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression; cancers associated with an infection
10/19/2006	US20060233818 Organic compounds
10/19/2006	US20060233813 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith
10/19/2006	US20060233808 Peptabody for cancer treatment
10/19/2006	US20060233807 Novel therapies and methods of screening for therapeutic compounds
10/19/2006	US20060233806 Removal promoters and inhibitor for apoptosis cells in vivo
10/19/2006	US20060233803 treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO: 32 in human, comprising administering an immunoadhesin comprising an extracellular domain sequence of the polypeptide; rheumatoid arthritis, pneumonia, chronic asthma, chronic hepatitis, osteoarthritis
10/19/2006	US20060233800 Biological products
10/19/2006	US20060233792 novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents
10/19/2006	US20060233788 Anti-ghrelin antibodies
10/19/2006	US20060233787 Human cd3-specific antibody with immunosuppressive properties
10/19/2006	US20060233782 Polypeptide; a deletion mutant of chondroitinase ABC Type I truncated by a deletion; retains its proteoglycan degrading activity; neurological functional recovery after central nervous system injury or disease
10/19/2006	US20060233771 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands
10/19/2006	US20060233760 Splicing variant of TGF-beta2 and uses thereof
10/19/2006	US20060233759 Adenoviral vectors having a protein IX deletion
10/19/2006	US20060233757 Vectors with viral insulators
10/19/2006	US20060233756 Recombinant adenoviral vectors and applications thereof
10/19/2006	US20060233754 A kit containing a compound promoting delivery of exogenous genes to cells, e.g., 1-(5-chloro-2-hydroxyphenyl)-3-(3-pyridinyl)-1,3-propanedione; 1-Tetradecylarsonic acid; N1-(2-fluoro-9-acridinyl)-N3N3-dimethyl-1,3-propanediamine; and N4(bis(2-chloroethy)amino)benzylidene)1,3-thiazol-2-amine
10/19/2006	US20060233753 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs
10/19/2006	US20060233749 Interleukin-19
10/19/2006	US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA
10/19/2006	US20060233742 cyclic peptides blocking of the Casein Kinase II (CKII) phosphorylation domain; HPV-16 cervical carcinoma cells; peptides increase the sensitivity of the cells to the cytostatic effect of IFN
10/19/2006	US20060233709 Method for identifying novel treatments of inflammatory disease in the gut
10/19/2006	US20060233706 Marked peptides having affinity for a phospholipid and uses
10/19/2006	DE10083676B4 Rekombinantes Enzym mit ausgezeichneter D-Aminosäureoxidaseaktivität sowie dessen Herstellung The recombinant enzyme with excellent D-Aminosäureoxidaseaktivität and its production
10/19/2006	CA2616085A1 Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation
10/19/2006	CA2605377A1 Ghrelin binding nucleic acids
10/19/2006	CA2604621A1 Identification of a beta-1,3-n-acetylgalactosaminyltransferase (cgte) from campylobacter jejuni lio87
10/19/2006	CA2604538A1 Hiv vaccine
10/19/2006	CA2604536A1 Conjugate comprising p21 protein for the treatment of cancer
10/19/2006	CA2604441A1 Composition and methods of rnai therapeutics for treatment of cancer and other neovascularization diseases
10/19/2006	CA2604377A1 Compositions and methods for the diagnosis and treatment of tumor
10/19/2006	CA2604299A1 Modified coagulation factor viii with enhanced stability and its derivates
10/19/2006	CA2604288A1 Use of a galectin-1-targeted rnai-based approach for the treatment of cancer
10/19/2006	CA2604241A1 Promoter for the expression of foreign genes in neuronal cells
10/19/2006	CA2604135A1 Pop2 nfkb-inhibiting polypeptides, nucleic acids and methods of use
10/19/2006	CA2604036A1 Cathepsin s antibody
10/19/2006	CA2603976A1 Methods for treating infectious disease exacerbated asthma
10/19/2006	CA2603944A1 Elite event a2704-12 comprising the integration of the phosphinothricin acetyltransferase (pat) gene into soybeans, and methods and kits for identifying such event in biological samples
10/19/2006	CA2603919A1 High-phosphate starch
10/19/2006	CA2603863A1 Gammaretrovirus associated with cancer
10/19/2006	CA2603842A1 Rnai therapeutic for respiratory virus infection
10/19/2006	CA2603780A1 Sema4d in cancer diagnosis, detection and treatment
10/19/2006	CA2603779A1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
10/19/2006	CA2603465A1 Identification of a new class of epsp synthases
10/19/2006	CA2603453A1 5-fluorouracil-resistant bacteria and method for production thereof
10/19/2006	CA2603264A1 Antibody substituting for function of blood coagulation factor viii
10/19/2006	CA2602793A1 A host cell comprising a vector for production of proteins requiring gamma-carboxylation
10/19/2006	CA2602665A1 Haemophilus influenzae type b
10/19/2006	CA2599302A1 Reducing levels of nicotinic alkaloids in plants
10/19/2006	CA2597789A1 Molecules and methods of using same for treating mcp-1/ccr2 associated diseases
10/19/2006	CA2592563A1 Nucliec acids encoding 5-enolpyruvylshikimate-3-phosphate (epsp) synthase
10/19/2006	CA2587848A1 Antiinfective lipopeptides
10/19/2006	CA2583735A1 Orthogonal translation components for the in vivo incorporation of unnatural amino acids
10/18/2006	EP1712916A1 Biological sample discriminating device, biological sample discriminating method, and biological sample discriminating plate
10/18/2006	EP1712636A1 Method of quickly measuring factor causing early flocculation of yeast
10/18/2006	EP1712632A2 Gene for a heat resistant enzymes of the amino acid biosynthetic pathway derived from thermophilic Coryneform bacteria
10/18/2006	EP1712631A2 Fc receptors and polypeptides
10/18/2006	EP1712630A1 Process for producing optically active alcohol and carboxylic acid
10/18/2006	EP1712629A2 Compounds and methods for diagnosis of tuberculosis
10/18/2006	EP1712628A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/18/2006	EP1712627A1 Polypeptide having amidase activity and gene thereof
10/18/2006	EP1712626A1 Unsaturated fatty acid synthase gene originating in marchantiales plant and utilization of the same
10/18/2006	EP1712625A1 An arabidopis thaliana transcription factoras well as the encoding gene and the use thereof
10/18/2006	EP1712624A1 Ires functioning in plant
10/18/2006	EP1712623A2 Selection of proteins using RNA-protein fusions
10/18/2006	EP1712622A1 Method of detecting target substance
10/18/2006	EP1712621A1 Gene markers linked to fusarium head blight-resistance factor and utilization thereof
10/18/2006	EP1712619A1 Preventive/remedy for cancer
10/18/2006	EP1712618A1 Method of amplifying nucleic acid and method of detecting mutated nucleic acid using the same
10/18/2006	EP1712617A1 The recombinant murine leukemia virus reverse transcriptase, the gene encoding it and the method for expressing it
10/18/2006	EP1712566A1 Inflammatory cytokine inhibitor
10/18/2006	EP1712565A1 Cell death inducing agents
10/18/2006	EP1712561A1 Silk thread containing spider thread protein and silkworm producing the silk thread
10/18/2006	EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
10/18/2006	EP1712126A1 Transgenic bird and method of constructing the same
10/18/2006	EP1712125A1 DISEASE MODEL ANIMAL EXPRESSING MEGSIN/RAGE/iNOS AND METHOD OF EVALUATING COMPOUND WITH THE USE OF THE ANIMAL
10/18/2006	EP1711635A1 Genes associated with canine osteoarthritis and related methods and compositions
10/18/2006	EP1711633A1 Diagnostic and therapeutic use of the kcne4 gene and protein for alzheimer disease
10/18/2006	EP1711615A2 Engineered templates and their use in single primer amplification
10/18/2006	EP1711614A2 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use
10/18/2006	EP1711613A2 Gene silencing by using micro-rna molecules
10/18/2006	EP1711612A1 Expression cassettes for the bi-directional transgenic expression of nucleic acids in plants
10/18/2006	EP1711611A2 Selection markers useful for heterologous protein expression
10/18/2006	EP1711610A2 HETERODIMERIC FOLLICLE STIMULATING HORMONE-Fc (FSH-Fc) FUSION PROTEINS FOR THE TREATMENT OF INFERTILITY
10/18/2006	EP1711609A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
10/18/2006	EP1711608A1 Differentiation regulating agent containing gene which regulating differentiation from stem cells into natural killer cells as effective ingredient
10/18/2006	EP1711607A2 Biosensor based on directed assembly of particles

1 ... 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 1743 1744 ... 4023